These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24258305)

  • 21. Iron deficiency, elevated erythropoietin, fibroblast growth factor 23, and mortality in the general population of the Netherlands: A cohort study.
    Eisenga MF; De Jong MA; Van der Meer P; Leaf DE; Huls G; Nolte IM; Gaillard CAJM; Bakker SJL; De Borst MH
    PLoS Med; 2019 Jun; 16(6):e1002818. PubMed ID: 31170159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intact Fibroblast Growth Factor 23 Concentrations in Hypophosphatemic Disorders.
    Ramos P; Larson B; Ashrafzadeh-Kian S; Ito N; Kato H; Bornhorst JA; Algeciras-Schimnich A
    Endocr Pract; 2023 Mar; 29(3):193-198. PubMed ID: 36627024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A decrease in serum 1,25(OH)
    Vaculik J; Wenchich L; Bobelyak M; Pavelka K; Stepan JJ
    J Endocrinol Invest; 2022 May; 45(5):1039-1044. PubMed ID: 35079976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated fibroblast growth factor 23 exerts its effects on placenta and regulates vitamin D metabolism in pregnancy of Hyp mice.
    Ohata Y; Yamazaki M; Kawai M; Tsugawa N; Tachikawa K; Koinuma T; Miyagawa K; Kimoto A; Nakayama M; Namba N; Yamamoto H; Okano T; Ozono K; Michigami T
    J Bone Miner Res; 2014 Jul; 29(7):1627-38. PubMed ID: 24470103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum fibroblast growth factor 23 is a useful marker to distinguish vitamin D-deficient rickets from hypophosphatemic rickets.
    Kubota T; Kitaoka T; Miura K; Fujiwara M; Ohata Y; Miyoshi Y; Yamamoto K; Takeyari S; Yamamoto T; Namba N; Ozono K
    Horm Res Paediatr; 2014; 81(4):251-7. PubMed ID: 24577200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations.
    Imel EA; DiMeglio LA; Hui SL; Carpenter TO; Econs MJ
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1846-50. PubMed ID: 20157195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production.
    David V; Martin A; Isakova T; Spaulding C; Qi L; Ramirez V; Zumbrennen-Bullough KB; Sun CC; Lin HY; Babitt JL; Wolf M
    Kidney Int; 2016 Jan; 89(1):135-46. PubMed ID: 26535997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibroblast growth factor 23 concentrations and modifying factors in children from age 12 to 24 months.
    Enlund-Cerullo M; Hauta-Alus H; Valkama S; Rosendahl J; Andersson S; Mäkitie O; Holmlund-Suila E
    Bone; 2020 Dec; 141():115629. PubMed ID: 32919110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibroblast growth factor 23 and its receptors.
    Yu X; White KE
    Ther Apher Dial; 2005 Aug; 9(4):308-12. PubMed ID: 16076372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intact and C-Terminal FGF23 Assays-Do Kidney Function, Inflammation, and Low Iron Influence Relationships With Outcomes?
    Sharma S; Katz R; Bullen AL; Chaves PHM; de Leeuw PW; Kroon AA; Houben AJHM; Shlipak MG; Ix JH
    J Clin Endocrinol Metab; 2020 Dec; 105(12):e4875-85. PubMed ID: 32951052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Administration of Ferric Citrate Hydrate Decreases Circulating FGF23 Levels Independently of Serum Phosphate Levels in Hemodialysis Patients with Iron Deficiency.
    Iguchi A; Kazama JJ; Yamamoto S; Yoshita K; Watanabe Y; Iino N; Narita I
    Nephron; 2015; 131(3):161-6. PubMed ID: 26551233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel SLC34A3 mutation causing hereditary hypophosphataemic rickets with hypercalciuria in a Gambian family.
    Braithwaite V; Pettifor JM; Prentice A
    Bone; 2013 Mar; 53(1):216-20. PubMed ID: 23246670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C-Terminal Fibroblast Growth Factor-23 Levels in Non-Nutritional Hypophosphatemic Rickets.
    Bharati J; Bhatia D; Khandelwal P; Gupta N; Sinha A; Khadgawat R; Hari P; Bagga A
    Indian J Pediatr; 2019 Jun; 86(6):555-557. PubMed ID: 30835073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral vitamin D
    Charoenngam N; Rujirachun P; Holick MF; Ungprasert P
    Osteoporos Int; 2019 Nov; 30(11):2183-2193. PubMed ID: 31372708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FGF23 analysis of a Chinese family with autosomal dominant hypophosphatemic rickets.
    Sun Y; Wang O; Xia W; Jiang Y; Li M; Xing X; Hu Y; Liu H; Meng X; Zhou X
    J Bone Miner Metab; 2012 Jan; 30(1):78-84. PubMed ID: 21710177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Value of serum fibroblast growth factor 23 in diagnosis of hypophosphatemic rickets in children].
    Dong SS; Che RC; Zheng BX; Zhang AH; Wang CL; Bai M; Chen Y
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 Jul; 25(7):705-710. PubMed ID: 37529952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women.
    Wolf M; Koch TA; Bregman DB
    J Bone Miner Res; 2013 Aug; 28(8):1793-803. PubMed ID: 23505057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibroblast growth-factor 23 and vitamin D are associated with iron deficiency and anemia in children with chronic kidney disease.
    Karava V; Dotis J; Kondou A; Christoforidis A; Taparkou A; Farmaki E; Economou M; Printza N
    Pediatr Nephrol; 2023 Aug; 38(8):2771-2779. PubMed ID: 36862253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenic role of Fgf23 in Dmp1-null mice.
    Liu S; Zhou J; Tang W; Menard R; Feng JQ; Quarles LD
    Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E254-61. PubMed ID: 18559986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-Terminal, but Not Intact, FGF23 and EPO Are Strongly Correlatively Elevated in Patients With Gain-of-Function Mutations in HIF2A: Clinical Evidence for EPO Regulating FGF23.
    Roszko KL; Brown S; Pang Y; Huynh T; Zhuang Z; Pacak K; Collins MT
    J Bone Miner Res; 2021 Feb; 36(2):315-321. PubMed ID: 33049075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.